# Labrys Biologics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/labrys-biologics

- Industry: Biotechnology
- Headquarters: San Mateo, US
- Website: www.labrysbiologics.com
- Total disclosed funding: $31M
- Latest round: Series A (Jan 3, 2013)
- Investors on record: 4

## About

Labrys Biologics, Inc. is a development stage biotechnology company focused on treatments for chronic migraine.

## Funding rounds

- Series A, Jan 3, 2013, $16M — InterWest Partners, Sofinnova Investments, Canaan Partners, VenBio
- Series A, Dec 21, 2012, $15M — InterWest Partners, Sofinnova Investments, Canaan Partners, VenBio

## Investors

- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series A
- Sofinnova Investments (https://capitalatlas.ai/funds/sofinnova-investments) — Series A
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series A
- VenBio (https://capitalatlas.ai/funds/venbio) — Series A